Translational Neurodegeneration (Apr 2020)

Correction to: Effectiveness and safety of opicapone in Parkinson’s disease patients with motor fluctuations: the OPTIPARK open-label study

  • Heinz Reichmann,
  • Andrew Lees,
  • José-Francisco Rocha,
  • Diogo Magalhães,
  • Patrício Soares-da-Silva,
  • the OPTIPARK investigators

DOI
https://doi.org/10.1186/s40035-020-00193-3
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 3

Abstract

Read online

An amendment to this paper has been published and can be accessed via the original article.